Impact of a vaccination promotion intervention using motivational interview techniques on long-term vaccine coverage: the PromoVac strategy.
Motivational interviewing
health promotion intervention
infants
maternity wards
vaccine coverage
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
2019
2019
Historique:
pubmed:
21
11
2018
medline:
27
2
2020
entrez:
21
11
2018
Statut:
ppublish
Résumé
Delayed vaccinations at 2, 4, and 6 months are associated with a higher probability of delayed age-appropriate vaccination during childhood. This study aimed to assess the effectiveness of an information session on immunization during infancy. An individual educational information session with motivational interview techniques for immunization of infants was conducted (experimental group) or not conducted (control group) during postpartum stay in a quasi-experimental cohort study. Immunization data were collected from the Eastern Townships Public Health registry at 3, 5, 7, 13, 19, and 24 months of age. Logistic regressions with repeated measures were performed to assess the intervention's impact. Relative risks (RR) were estimated. A multivariate model was obtained adjusted for confounding factors. The experimental and control groups included 1140 and 1249 families, respectively. In per protocol analysis, a significant increase in VC of 3.2, 4.9, 7.3, 6.7, 10.6, and 5.1% was observed at 3, 5, 7, 13, 19, and 24 months. Children from experimental group had 9% more chance at a complete vaccination status between 3 and 24 months compared to children from control group (RR (95% CI): 1.09 (1.05-1.13), p < .001). Children with complete vaccination status at 3 months were more likely to have a complete vaccination status at 24 months (82.3 vs. 48.1%, RR (95% CI): 2.72 (2.28-3.24), p < .001). After adjustment, the estimated RR of the intervention's impact was 1.05 (1.02-1.07), p < .001. An educational information session about immunization based on motivational interview techniques conducted during postpartum hospitalization could improve immunization during infancy.
Sections du résumé
BACKGROUND
Delayed vaccinations at 2, 4, and 6 months are associated with a higher probability of delayed age-appropriate vaccination during childhood. This study aimed to assess the effectiveness of an information session on immunization during infancy.
METHODS
An individual educational information session with motivational interview techniques for immunization of infants was conducted (experimental group) or not conducted (control group) during postpartum stay in a quasi-experimental cohort study. Immunization data were collected from the Eastern Townships Public Health registry at 3, 5, 7, 13, 19, and 24 months of age. Logistic regressions with repeated measures were performed to assess the intervention's impact. Relative risks (RR) were estimated. A multivariate model was obtained adjusted for confounding factors.
RESULTS
The experimental and control groups included 1140 and 1249 families, respectively. In per protocol analysis, a significant increase in VC of 3.2, 4.9, 7.3, 6.7, 10.6, and 5.1% was observed at 3, 5, 7, 13, 19, and 24 months. Children from experimental group had 9% more chance at a complete vaccination status between 3 and 24 months compared to children from control group (RR (95% CI): 1.09 (1.05-1.13), p < .001). Children with complete vaccination status at 3 months were more likely to have a complete vaccination status at 24 months (82.3 vs. 48.1%, RR (95% CI): 2.72 (2.28-3.24), p < .001). After adjustment, the estimated RR of the intervention's impact was 1.05 (1.02-1.07), p < .001.
CONCLUSIONS
An educational information session about immunization based on motivational interview techniques conducted during postpartum hospitalization could improve immunization during infancy.
Identifiants
pubmed: 30457421
doi: 10.1080/21645515.2018.1549451
pmc: PMC6988881
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
732-739Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Vaccine. 2006 Aug 31;24 Suppl 3:S3/201-9
pubmed: 16950008
Pediatrics. 2014 Apr;133(4):e835-42
pubmed: 24590751
Nat Med. 2005 Apr;11(4 Suppl):S20-4
pubmed: 15812485
Can Commun Dis Rep. 2004 Mar 15;30(6):53-9
pubmed: 15061307
Law Hum Behav. 2010 Dec;34(6):501-16
pubmed: 20076997
Vaccine. 2015 Aug 14;33(34):4191-203
pubmed: 25896385
MMWR Morb Mortal Wkly Rep. 1999 Apr 2;48(12):241-3
pubmed: 10220250
Can J Public Health. 2003 May-Jun;94(3):218-23
pubmed: 12790498
Patient Educ Couns. 2004 May;53(2):147-55
pubmed: 15140454
Vaccine. 2007 May 16;25(20):3996-4002
pubmed: 17395344
Lancet Infect Dis. 2016 May;16(5):518-519
pubmed: 26852724
Vaccine. 2006 Jan 30;24(5):644-51
pubmed: 16157423
Br J Gen Pract. 2005 Apr;55(513):305-12
pubmed: 15826439
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5791-6
pubmed: 23536293
Am J Health Promot. 2014 Sep-Oct;29(1):e32-42
pubmed: 24670068
JAMA. 2005 Mar 9;293(10):1204-11
pubmed: 15755943
Vaccine. 2004 Oct 22;22(31-32):4228-32
pubmed: 15474712
BMC Public Health. 2007 Oct 25;7:304
pubmed: 17961209
Cochrane Database Syst Rev. 2013 May 31;(5):CD010038
pubmed: 23728698
Am J Prev Med. 2003 Jul;25(1):45-9
pubmed: 12818309
J Consult Clin Psychol. 1983 Jun;51(3):390-5
pubmed: 6863699
Am J Public Health. 2004 Mar;94(3):361-6
pubmed: 14998794
Am J Prev Med. 2000 Jan;18(1 Suppl):97-140
pubmed: 10806982
Vaccine. 2011 Feb 17;29(9):1824-9
pubmed: 21219988
Arch Pediatr Adolesc Med. 1994 Sep;148(9):943-9
pubmed: 8075738
Public Health Rep. 2004 Mar-Apr;119(2):144-55
pubmed: 15192901
Res Nurs Health. 2010 Apr;33(2):120-32
pubmed: 20143328
Vaccine. 2013 Sep 13;31(40):4293-304
pubmed: 23859839
Am J Prev Med. 2000 Jan;18(1 Suppl):35-43
pubmed: 10806978
BMC Public Health. 2018 Jun 28;18(1):811
pubmed: 29954370
Annu Rev Clin Psychol. 2005;1:91-111
pubmed: 17716083